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Liver Fibrosis Assessment by 
Point Shear-Wave Elastography 
Techniques
Roxana Șirli, Alina Popescu and Ioan Sporea
Abstract
Point shear-wave elastographic (pSWE) techniques use acoustic radiation 
force impulse (ARFI) to stimulate the liver tissue and to generate shear waves that 
propagate into the liver. The shear-wave velocity (SWV) increases with the sever-
ity of fibrosis. The first type of pSWE was Virtual Touch Quantification (VTQ ) 
developed by Siemens, followed by ElastPQ by Philips, and nowadays pSWE is 
available on other systems (Hitachi, Esaote, Samsung). To evaluate liver fibrosis by 
pSWE, ten valid measurements are performed in the right liver lobe; a median value 
is calculated, with the results expressed in meters/second or in kilopascals (kPa) 
(if the operator chooses). VTQ is a reproducible method, the intraclass correlation 
coefficient (ICC) for inter- and intraobserver measurements ranging from 0.81 
to 0.87. Confounding factors for VTQ are non-fasting conditions, elevated ami-
notransferases, congestive heart failure, and extrahepatic cholestasis. In patients 
with chronic hepatopathies, the AUROCs for predicting significant fibrosis range 
between 0.75 and 0.85 and for predicting cirrhosis between 0.85 and 0.95. There 
were promising results regarding the value of VTQ to predict liver cirrhosis compli-
cations, especially portal hypertension. ElastPQ is a newly developed point shear-
wave elastographic method (from Philips). Only few data were published but with 
promising results.
Keywords: liver fibrosis, liver elastography, point shear-wave elastography, Virtual 
Touch Quantification, ElastPQ
1. Introduction
Evaluation of liver fibrosis severity is essential in chronic hepatopathies, espe-
cially for prognosis, but also for decision regarding treatment in some cases or 
for follow-up [1]. For a long time, liver biopsy was considered to be the reference 
method for fibrosis assessment. Not only mainly due to its invasiveness [2] but also 
due to issues regarding inter-observer variability and sampling errors [3], nonin-
vasive methods have been developed to assess the severity of liver fibrosis. These 
methods can be either biological or elastographic [1].
Elastographic techniques are based on an intrinsic property of tissue elasticity. 
When an extrinsic force is applied to a tissue, it deforms more or less according to 
its elasticity. Less elastic, stiffer tissue deforms less when subjected to an external 
force. Elastographic techniques measure tissue displacement when subjected to 
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an external force. In chronic hepatopathies, as fibrosis progresses, the liver tissue 
becomes stiffer, less elastic; thus, liver stiffness (LS) is considered to be an indicator 
of liver fibrosis severity [1, 4, 5]. Elastographic techniques can be ultrasound-based 
or based on magnetic resonance imaging.
According to the latest guidelines [4–9], ultrasound-based elastographic tech-
niques are divided into strain elastography (which measures longitudinal displace-
ment) and shear-wave elastography (SWE—which measures the speed of the shear 
waves generated into the tissue when an external force is applied). Based on the 
type of impulse that generates the shear waves, SWE is subdivided into transient 
elastography (TE—where a mechanical stimulus is applied to the tissue) and 
acoustic radiation force impulse (ARFI) techniques (where the stimulus deforming 
the tissue is an acoustic “push pulse” generated by the transducer). Subsequently, 
ARFI elastography is subdivided into point SWE (in which LS is measured in a 
region of interest (ROI)) and multidimensional SWE (2D-SWE and 3D-SWE—in 
which a color-coded elastogram is obtained and shear-wave speed is also measured 
in a region of interest).
In the following pages, we will present point shear-wave elastography 
techniques.
2. Point shear-wave elastography: basic principles
pSWE is a type of SWE in which tissue stimulation is performed at a certain 
depth by an acoustic radiation force impulse generated by the transducer (ARFI 
technology), which generates shear waves that propagate into the tissue, perpen-
dicularly on the axis of the initial pulse. Shear-wave velocity (SWV), expressed 
in meters/second (m/s), is measured in a predefined ROI chosen by the operator 
while performing B-mode ultrasonography. The average propagation speed of the 
shear waves, from a point placed on the lateral margin of the ROI to an opposite 
point on the ROI, can be measured by detecting its time of arrival at that point, 
relative to the acoustic “push” pulse [5]. The stiffer the tissue, the higher the shear-
wave velocity [4–9].
Most systems performing pSWE allow the choice to express measurement 
results either in m/s or in kilopascals (kPa). Kilopascal is the unit of the elastic 
modulus, obtained by converting the SWV to an elastic modulus, using an equa-
tion that assumes that the tissue density is always the same and also that the elastic 
modulus is not influenced by the magnitude, frequency, and direction of the 
applied force [5]. Thus, even if kPa is the unit to which users are the most familiar 
(since it was used for Transient Elastography), the most correct one is m/s [5–7].
Two types of pSWE have been more thoroughly evaluated, the ones developed 
by Siemens (Virtual Touch Quantification) and by Philips (ElastPQ ). Currently 
other manufacturers also offer pSWE on their systems: Esaote, Hitachi, and 
Samsung [5].
3. Point shear-wave elastography (pSWE): examination technique
First of all, before performing SWE the operator should be trained [5, 6, 8, 9]. If 
for TE training means performing more than 100 examinations under supervision 
[10], what training means is less precise for pSWE. A study published by Boursier 
concluded that there is no training effect on the accuracy of LS measurements by 
VTQ (ARFI) [11]. Concerning ElastPQ , a published study concluded that after a 
1-year learning curve, or 130 examinations, the accuracy of ElastPQ matches that 
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of TE [12]. Considering that adequate B-mode image is a must for reliable pSWE 
measurements [5, 9], it is sensible to consider that training not only in elastographic 
measurements but also in ultrasonography is needed.
According to the guidelines, the recommended technique of pSWE mea-
surements is with the patient in supine position with the right arm in maximal 
extension, through an intercostal approach, during breath hold, avoiding deep 
inspiration or expiration [5, 6, 8]. The transducer should be perpendicular on the 
liver capsule, and the ROI should be placed in the right liver lobe, as to avoid large 
blood vessels and masses, at a depth of minimum 1 cm below the liver capsule, best 
at 4–5 cm from the transducer [5, 6, 8, 9] (Figures 1 and 2).
A study published by our group demonstrated that the best correlation of VTQ 
measurements with histology was obtained for SWV measurements made 1–2 and 
2–3 cm beneath the liver capsule but with a lower feasibility for deeper measure-
ments [13]. Several studies observed higher SWV by VTQ in the left liver lobe 
vs. the right liver lobe [14–16]. Regarding ElastPQ , measurements made in liver 
segment V had the lowest coefficient of variation, and SWVs at the end-expiration 
were significantly higher than that at the end-inspiration [17].
For an appropriate estimation of fibrosis, the guidelines recommend to perform 
ten pSWE measurements and to calculate the median (M) value [5, 6, 8, 9]. When 
VTQ was launched, the manufacturer did not recommend quality criteria, but 
several studies demonstrated that there is a better correlation between histologic 
fibrosis and pSWE measurements if quality criteria such as interquartile range 
(IQR) and success rate (SR) are met. Regarding VTQ , an IQR/M ≥ 30% was 
associated with a discordance of at least two stages of fibrosis between SWV and 
histologic fibrosis [18]. In another study from our group, a very strong correlation 
of VTQ measurements with histologic fibrosis was observed when quality param-
eters (IQR < 30% and SR ≥ 60%) were met (r = 0.722, p < 0.0001); if not, there 
was no significant correlation (r = 0.268, p = 0.07) [19]. Also, standard deviation 
(SD) of the mean of ten valid SWV measurements by VTQ was evaluated as a 
quality criterion. Exclusion of patients in whom the SD was higher than 30% lead 
to an improved accuracy of VTQ [20]. Regarding ElastPQ®, IQR/M ≤ 30% is also 
the most important quality criterion [21, 22]. European guidelines recommend as 
quality criterion for pSWE an IQR/M ≤ 30% [5, 8], while the WFUMB guidelines 
Figure 1. 
VTQ measurement.
Ultrasound Elastography
4
recommend an even smaller IQR/M, of less than 15%, if results are expressed in m/s 
[9]. A new multicenter study with ElastPQ® showed that the median value of five 
measurements with an IQR/M ≤ 30% is accurate enough for daily practice [22].
4.  Point shear-wave elastography (pSWE): feasibility and 
reproducibility
As opposed to TE, pSWE is feasible in patients with ascites [5, 6, 8, 9]. 
Furthermore, in published studies, the feasibility is better as compared to TE, being 
higher than 92%, both in VTQ [11, 23–25] and in ElastPQ [26, 27]. In a multicenter 
study on VTQ , older age, higher BMI, and male gender were associated with failed 
and unreliable measurements [25].
Regarding reproducibility of VTQ , several studies demonstrated very good 
inter- and intraobserver reproducibility, with intraclass correlation coefficients 
(ICC) higher than 0.81 [10, 28, 29]. A study that evaluated factors that influenced 
reproducibility found out that intraoperator reproducibility was better than the 
inter-operator one (ICC of 0.90 vs. 0.81) [28]. Both intra- and inter-operator repro-
ducibilities were better in men than in women, in patients with lower BMI, and in 
patients with no ascites and in cirrhotic than in non-cirrhotic patients [28].
ElastPQ was also proved to be a reproducible method, reported ICC ranging 
from 0.798 [30] to 0.96 [31]. In a study published by Fraquelli, the reproducibility 
was influenced by training, but not by age, gender, BMI, liver enzymes, and liver 
etiology [12].
5. Point shear-wave elastography (pSWE): confounding factors
One of the first confounding factors that should be taken into consideration is 
examination in non-fasting conditions. In a study published by our group, it was 
demonstrated that food intake can lead to a significant increase in SWVs measured 
by VTQ in healthy volunteers 1 hour post meal, the values decreasing to baseline 
3 hours after the meal [32]. Even if no data was published regarding ElastPQ , the 
Figure 2. 
ElastPQ measurement.
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observation in VTQ was similar to what happens with TE measurements in non-
fasting patients, and thus the guidelines recommendation that pSWE measure-
ments should be performed in fasting patients [5, 6, 8, 9].
Another factor that can lead to a falsely increased SWV measured by VTQ is 
physical exercise [33]. Thus, the EFSUMB guidelines recommend that SWE should 
be performed after a minimum 10 minutes of rest [5].
An important confounding factor for SWE is liver necroinflammation, objecti-
fied by elevated aminotransferase levels. Several studies demonstrated that elevated 
aminotransferase levels are associated with higher SWVs by VTQ for the same 
severity of liver fibrosis, as compared to those observed in patients with normal 
or only slightly elevated aminotransferases [34, 35]. Also, a significant decrease in 
SWVs was observed in a case report of acute liver failure, in parallel to the normal-
ization of liver function tests [36].
The influence of necroinflammation on SWVs measured by ElastPQ is con-
troversial. In a study by Ma et al., the grade of necroinflammatory activity was 
independently associated with higher ElastPQ values [30], while in the study of 
Ferraioli et al., it had no influence [31].
Similar to TE, other confounding factors, which falsely increase SWVs by pSWE 
are right heart failure [37] and the presence of extrahepatic cholestasis [38].
Considering all the studies mentioned above, EFSUMB and WFUMB guidelines 
caution about the confounding factors for pSWE and state that liver inflammation 
(indicated by AST and/or ALT elevation >5 times the normal limits), obstructive 
cholestasis, liver congestion, acute hepatitis, and infiltrative liver diseases should be 
excluded before pSWE to avoid overestimation of fibrosis and/or should be consid-
ered when interpreting the results [5, 9].
6.  Point shear-wave elastography (pSWE): normal values  
in a healthy liver
The SWV by pSWE in healthy livers were evaluated by several authors. 
Regarding VTQ , normal SWV values ranged between 1.07 and 1.19 m/s [15, 39–42], 
and they were not influenced by gender and age, but higher values were observed in 
the left liver lobe than in the right liver lobe [15].
Regarding ElastPQ , normal values are in the same range as for VTQ [17, 31, 43], 
but a study found higher values in men than in women [17].
Current guidelines state that SWE measurements in the liver in normal range 
can rule out significant fibrosis if they are in accordance with clinical and biologic 
data [5, 9].
7.  Point shear-wave elastography (pSWE) in patients with chronic 
hepatopathies
7.1 Mixed cohorts
Multiple studies have been published regarding the value of VTQ elastography 
in patients with chronic liver diseases, considering biopsy as the reference. We sum-
marized some of them in Table 1.
Four meta-analyses were published regarding the value of VTQ for liver fibrosis 
assessment. The first one, by Friedrich-Rust et al., included 518 patients with 
hepatopathies of various etiologies. The summary AUROCs of VTQ for predicting 
significant fibrosis (F ≥ 2), severe fibrosis (F ≥ 3), and cirrhosis were 0.87, 0.91, 
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and 0.93, respectively. TE performed significantly better than VTQ for F2 and cir-
rhosis, while for F3 the performances evaluated by AUROC were similar [51].
The second one included 1163 patients with chronic hepatopathies evaluated by 
LB, TE, and VTQ [52]. The first conclusion was that VTQ had a better feasibility 
than TE (unreliable measurements in 2.1 vs. 6.6% cases, respectively, p < 0.001). 
The diagnostic odds ratios were similar for VTQ and TE for detection of significant 
fibrosis and cirrhosis. The mean optimal cutoff value of VTQ for the detection of F2 
was 1.30 ± 0.07 m/s, and for cirrhosis, it was 1.80 ± 0.16 m/s.
The third meta-analysis included 3951 patients with liver biopsy as reference 
method. The AUROCs of VTQ for predicting the presence of F2, F3, and cirrhosis 
were 0.84, 0.89, and 0.91, respectively [53].
Finally, the fourth meta-analysis including 2691 patients calculated global 
sensitivity and specificity of VTQ to predict any stage of fibrosis to be 79 and 86%, 
respectively. The performance of VTQ was higher for more advanced fibrosis: 
for F ≥ 3 84% Se and 90% Sp (AUROC—0.94), while for F4 86% Se and 84% Sp 
(AUROC—0.91) [54].
Regarding ElastPQ , few data are available. In a study that compared ElastPQ 
to TE considered as reference, ElastPQ had a better feasibility than TE: 98.7% vs. 
90.7%. The AUROCs calculated for significant fibrosis, severe fibrosis, and cirrhosis 
were 0.94, 0.97, and 0.97, respectively [27].
7.2 Chronic hepatitis C
There is a lot of published data regarding the performance of VTQ elastography 
for the assessment of liver fibrosis in patients with chronic hepatitis C, as shown in 
Table 2.
To summarize, according to EFSUMB guidelines, VTQ® cutoffs of 1.21–1.34 m/s 
predict significant fibrosis (F ≥ 2) (AUROC 0.85–0.89), while VTQ® cutoffs 
between 1.55 and 2 m/s (AUROC 0.89–0.93) predict cirrhosis [5]. Furthermore, 
Study Etiology F2 F4
AUROC 
TE
Cutoff 
AUROC 
VTQ
AUROC 
TE
Cutoff
AUROC 
VTQ
Friedrich-Rust 
et al. [44]
86 patients
HBV + HCV
0.86 1.37 m/s
0.86
0.91 1.75 m/s
0.91
Sporea et al. 
[45]
223 patients
Healthy + HBV + HCV
0.953 1.27 m/s
0.890
0.985 1.7 m/s
0.931
Takahashi 
et al. [46]
80 patients
Healthy + HBV + HCV
— 1.34 m/s
0.94
— 1.8 m/s
0.96
Goertz et al. 
[47]
57 patients
HBV + HCV
— 0.85 — 0.87
Ebinuma et al. 
[48]
131 patients
Mixed
0.871 1.3 m/s
0.891
0.817 1.88 m/s
0.888
Colombo et al. 
[49]
68
Healthy + mixed
0.897 0.922 0.815 0.934
Cassinotto 
et al. [50]
349
Mixed
0.84 0.81 0.90 0.90
Table 1. 
Performance of VTQ in the assessment of liver fibrosis in cohorts of patients with mixed etiologies of chronic 
hepatopathies, considering LB as the reference method.
7Liver Fibrosis Assessment by Point Shear-Wave Elastography Techniques
DOI: http://dx.doi.org/10.5772/intechopen.87212
according to recommendation 17 of the same guidelines, “pSWE as demonstrated 
with VTQ® can be used as the first-line assessment for the severity of liver fibrosis 
in patients with chronic viral hepatitis C. It performs best with regard to the ruling 
out of cirrhosis.”
Data regarding the value of ElastPQ for the assessment of liver fibrosis severity 
in chronic hepatitis C is scarce. In a pilot study, the AUROCs of VTQ for predicting 
F2, F3, and F4 were 0.80, 0.88, and 0.95, respectively [31]. Similar results have been 
obtained in a more recent study [60].
Following successful antiviral HCV treatment, a significant decrease of VTQ 
values was observed in a study performed by Goertz et al. [61].
7.3 Chronic hepatitis B
Several studies have been published regarding the value of VTQ for liver fibrosis 
assessment in chronic hepatitis B, as shown in Table 3.
Sub-analysis of data regarding patients with HBV chronic hepatitis from the 
Nierhoff meta-analysis on VTQ calculated AUROCs of 0.88 for F2 and 0.93 for F4, 
with cutoffs of 1.35 and 1.87 m/s, respectively [53].
Data regarding ElastPQ and chronic HBV hepatitis is scarce, and validation is 
needed. In a study that compared ElastPQ to liver biopsy in chronic hepatitis B, 
the authors calculated an AUROC of 0.94 with a cutoff of 6.99 kPa for F2 and an 
AUROC of 0.89 with a cutoff of 9.00 kPa for cirrhosis [30].
Regarding HBV chronic hepatitis and pSWE, EFSUMB guidelines state that 
“pSWE as demonstrated with VTQ is useful in patients with CHB to identify those 
with cirrhosis” [5].
7.4 Nonalcoholic fatty liver disease (NAFLD)
Several studies have been published regarding VTQ in the evaluation of liver 
fibrosis in NAFLD patients. Data is presented in Table 4.
Study Reference 
method
F ≥ 2 F ≥ 3 F = 4
Cutoff 
(m/s)
AUROC Cutoff 
(m/s)
AUROC Cutoff 
(m/s)
AUROC
Friedrich-
Rust et al. 
[44]
LB—64 p 1.35 0.86 1.55 0.93 1.75 0.95
Lupșor et al. 
[23]
LB—112 p 1.34 0.851 1.61 0.869 2 0.945
Sporea et al. 
[55]
LB—274 p 1.21 0.893 1.58 0.908 1.82 0.937
Sporea et al. 
[56]
LB—914 p 1.33 0.792 1.43 0.829 1.55 0.842
Rizzo et al. 
[57]
LB—139 p 1.3 0.86 1.7 0.94 2 0.89
Chen et al. 
[58]
LB—127 p 1.55 0.847 1.81 0.902 1.98 0.831
Li et al. [59] LB—128 p 1.53 0.775 1.79 0.901 1.79 0.792
Table 2. 
Performance of VTQ in the assessment of liver fibrosis in patients with chronic hepatitis C.
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A recently published meta-analysis including 723 patients who evaluated 
VTQ as a predictor of liver fibrosis in NAFLD patients calculated a summary 
sensitivity and specificity of VTQ in detecting significant fibrosis of 80.2 and 
85.2%, respectively, with a pooled diagnostic odds ratio of 30.13 and with an 
AUROC of 0.898 [68].
Considering all these data, EFSUMB guidelines conclude that VTQ can be used 
to exclude cirrhosis in NAFLD patients [5].
8.  Point shear-wave elastography (pSWE) for the prediction of liver 
cirrhosis complications
Cirrhosis is the final stage of chronic hepatopathies and can have severe com-
plications such as portal hypertension, hepatocellular carcinoma, decompensa-
tion, etc. The measurement of hepatic vein pressure gradient (HVPG) is the most 
accurate method for portal hypertension assessment, but it is an invasive method. 
HVPG >10 mm Hg means clinically significant portal hypertension (CSPH), while 
HVPG >12 mm Hg is predictive for variceal bleeding [69].
8.1 Portal hypertension
An initial study found a good correlation (r = 0.709) of VTQ measurements to 
HVPG measurements in 48 patients, with the AUROC for predicting CSPH being 
0.874 [70]. In a Romanian study in 145 patients, the mean value of VTQ measure-
ments in patients with grades 2 and 3 esophageal varices (EV) was significantly 
higher than the one in patients with no or small EV (3.06 ± 0.67 vs. 2.81 ± 0.80, 
p = 0.03) [71].
Study Reference 
method
F ≥ 3 F = 4
Cutoff 
(m/s)
AUROC Cutoff 
(m/s)
AUROC
Yoneda et al. [65] LB—54 p 1.77 0.973 1.9 0.976
Friedrich-Rust et al. [66] LB—61 p — 0.71 — 0.74
Fierbinteanu et al. [67] LB—64 p — 0.944 — 0.984
Table 4. 
Performance of VTQ in the assessment of liver fibrosis in patients with nonalcoholic fatty liver disease.
Study Reference 
method
F ≥ 2 F ≥ 3 F = 4
Cutoff 
(m/s)
AUROC Cutoff 
(m/s)
AUROC Cutoff 
(m/s)
AUROC
Friedrich 
Rust et al. 
[62]
LB—133 p — 0.69 — 0.83 — 0.96
Zhang et al. 
[63]
LB—180 p 1.63 0.764 1.74 0.852 2 0.825
Dong et al. 
[64]
LB—81 p 1.29 0.762 1.54 0.882 1.83 0.732
Table 3. 
Performance of VTQ in the assessment of liver fibrosis in patients with chronic hepatitis B.
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Several studies have evaluated SWVs in the spleen for the prediction of portal 
hypertension, with conflicting results. In the study by Rifai et al., spleen SWVs per-
formed better than liver SWVs for predicting CSPH [72]. In the study by Vermehren 
et al., spleen SWV and liver SWV had similar AUROCs for predicting the presence 
of at least grade 2 EV, but multiple regression analysis showed that spleen measure-
ments performed better [73]. In the study of Takuma et al., spleen VTQ measure-
ments also performed better than in the liver to predict the presence of varices in a 
cohort of 340 cirrhotic patients [74].
No data is available regarding ElastPQ.
However, according to the EFSUMB guidelines “reliable cut-offs are not avail-
able yet and no strong recommendation regarding the cut-offs to be used can be 
made due to the limited evidence” [5].
8.2 Hepatocellular carcinoma (HCC)
Published data showed only poor value of VTQ to predict the occurrence of 
HCC, with an AUROC of 0.54 [73].
There is no data regarding ElastPQ.
9. Point shear-wave elastography (pSWE): perspectives
Even if pSWE is currently implemented in other systems than from Siemens and 
Philips, published studies are small or missing altogether.
pSWE technique implemented on the Hitachi Ascendus system was evaluated 
by a study published in 2017 [75]. Reliable SWV measurements (SWM) were 
obtained in 87.2% of the 445 patients included. Considering TE as the reference 
method, cutoff values for pSWE from Hitachi had been calculated to rule in and 
rule out patients with significant fibrosis (F ≥ 2) and cirrhosis, respectively. SWV 
were converted to elastic modulus and expressed in kPa. To rule in F ≥ 2, the 
SWM cutoff was 6.78 kPa, while to rule it out, it was 5.55 kPa (AUROC—0.92). To 
rule in cirrhosis, the SWM cutoff was 9.15 kPa, and to rule it out, it was 8.41 kPa 
(AUROC—0.94).
A very interesting idea is to combine several techniques in order to assess not 
only fibrosis severity but also steatosis and inflammation using the same ultrasound 
machine. pSWE was combined with strain elastography on a Hitachi system. A 
study evaluated 388 patients with this combined technique, considering liver biopsy 
as reference method [76]. The AUROCs to predict fibrosis stage were 0.87, 0.80, 
0.83, and 0.80 for F1, F2, F3, and F4, respectively, while the AUROCs for activity 
grade were 0.94, 0.74, and 0.76 for A1, A2, and A3, respectively.
10. Conclusion
pSWE is an easy to perform elastographic technique, integrated into a standard 
ultrasound machine, with similar performance to TE to predict fibrosis severity in 
patients with hepatopathies of various etiologies, the performance increasing with 
the fibrosis severity.
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